Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Moss

Showing results (181-190 of 307) with videos related to

Pageof 31
Sort By:
Journal of Virology|September 16, 2004
Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virionsChristiana Fogg, Shlomo Lustig, J Charles Whitbeck, et al.
Journal of Virology|January 19, 2018
Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant RolesBaoming Liu, Debasis Panda, Jorge D Mendez-Rios, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
The 2.3 Å Structure of A21, a Protein Component of the Conserved Poxvirus Entry-Fusion ComplexUlrike S Diesterbeck, Liya A Muslinkina, Apostolos G Gittis, et al.
Journal of Virology|July 5, 2002
Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surfaceRob J Center, Richard D Leapman, Jacob Lebowitz, et al.
Journal of Molecular Biology|March 21, 2025
The 2.3 Å Structure of A21, a Protein Component of the Conserved Poxvirus Entry-Fusion ComplexUlrike S Diesterbeck, Liya A Muslinkina, Apostolos G Gittis, et al.
Journal of Virology|July 29, 2011
Expression profiling of the intermediate and late stages of poxvirus replicationZhilong Yang, Sara E Reynolds, Craig A Martens, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2005
The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodiesHua-Poo Su, Scott C Garman, Timothy J Allison, et al.
Journal of Virology|December 13, 2002
Overcoming immunity to a viral vaccine by DNA priming before vector boostingZhi-yong Yang, Linda S Wyatt, Wing-Pui Kong, et al.
Plos Pathogens|September 1, 2020
Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cellsChen Peng, Linda S Wyatt, Shira G Glushakow-Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2013
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesisGilad Sivan, Scott E Martin, Timothy G Myers, et al.
Pageof 31

Showing results (181-190 of 307) with videos related to

Sort By:
Pageof 31
Journal of Virology|September 16, 2004
Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virionsChristiana Fogg, Shlomo Lustig, J Charles Whitbeck, et al.
Journal of Virology|January 19, 2018
Identification of Poxvirus Genome Uncoating and DNA Replication Factors with Mutually Redundant RolesBaoming Liu, Debasis Panda, Jorge D Mendez-Rios, et al.
Biorxiv : the Preprint Server for Biology|June 26, 2025
The 2.3 Å Structure of A21, a Protein Component of the Conserved Poxvirus Entry-Fusion ComplexUlrike S Diesterbeck, Liya A Muslinkina, Apostolos G Gittis, et al.
Journal of Virology|July 5, 2002
Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surfaceRob J Center, Richard D Leapman, Jacob Lebowitz, et al.
Journal of Molecular Biology|March 21, 2025
The 2.3 Å Structure of A21, a Protein Component of the Conserved Poxvirus Entry-Fusion ComplexUlrike S Diesterbeck, Liya A Muslinkina, Apostolos G Gittis, et al.
Journal of Virology|July 29, 2011
Expression profiling of the intermediate and late stages of poxvirus replicationZhilong Yang, Sara E Reynolds, Craig A Martens, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 12, 2005
The 1.51-Angstrom structure of the poxvirus L1 protein, a target of potent neutralizing antibodiesHua-Poo Su, Scott C Garman, Timothy J Allison, et al.
Journal of Virology|December 13, 2002
Overcoming immunity to a viral vaccine by DNA priming before vector boostingZhi-yong Yang, Linda S Wyatt, Wing-Pui Kong, et al.
Plos Pathogens|September 1, 2020
Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cellsChen Peng, Linda S Wyatt, Shira G Glushakow-Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2013
Human genome-wide RNAi screen reveals a role for nuclear pore proteins in poxvirus morphogenesisGilad Sivan, Scott E Martin, Timothy G Myers, et al.
Pageof 31